See up to 3 months of IRMD. The 7-day demo opens the 1M and 3M ranges and puts IRMD on your watchlist.
Start 7-day demoLatest IRMD insider trades
Monty K. Allen - DirectorOpen-market sale
About IRADIMED CORP (IRMD)
IRADIMED CORP files with the SEC under CIK 0001325618 and is classified as surgical and medical instruments and apparatus. We track it alongside the rest of the Health Care sector.
IRMD Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 2 | 1,419 | $123K |
| Option exercise | 2 | 1,396 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
IRMD insider transactions (Form 4)
5055 Form 4 filings on record, the earliest from Oct 15, 2024, newest first. Filing history page 2 of 2.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Roger E. Susi - Officer | Open-market sale | Common Stock | 58 | $79.12 footnote F4 | $5K | |
| Roger E. Susi - Officer | Open-market sale | Common Stock | 4,242 | $77.56 footnote F2 | $329K | |
| Roger E. Susi - Officer | Open-market sale | Common Stock | 700 | $78.33 footnote F3 | $55K | |
| ||||||
| Roger E. Susi - Officer | Open-market sale | Common Stock | 3,577 | $74.58 footnote F2 | $267K | |
| Roger E. Susi - Officer | Open-market sale | Common Stock | 1,423 | $75.41 footnote F3 | $107K | |
| ||||||
| Hilda Frederique Scharen-Guivel | Option exercise | Common Stock | 1,767 | - footnote F1 | - | |
| Hilda Frederique Scharen-Guivel | Option exercise | Restricted Stock Units | 1,767 | $0.00 | - | |
| ||||||
| Roger E. Susi - Officer | Open-market sale | Common Stock | 3,227 | $72.16 footnote F2 | $233K | |
| Roger E. Susi - Officer | Open-market sale | Common Stock | 1,746 | $73.37 footnote F3 | $128K | |
| Roger E. Susi - Officer | Open-market sale | Common Stock | 27 | $74.07 footnote F4 | $2K | |
| ||||||
| Roger E. Susi - Officer | Open-market sale | Common Stock | 4,800 | $71.70 footnote F2 | $344K | |
| Roger E. Susi - Officer | Open-market sale | Common Stock | 200 | $72.27 | $14K | |
| ||||||
| Roger E. Susi - Officer | Open-market sale | Common Stock | 1,123 | $69.20 footnote F2 | $78K | |
| Roger E. Susi - Officer | Open-market sale | Common Stock | 3,448 | $70.41 footnote F3 | $243K | |
| Roger E. Susi - Officer | Open-market sale | Common Stock | 429 | $71.03 footnote F4 | $30K | |
| ||||||
| Roger E. Susi - Officer | Open-market sale | Common Stock | 5,000 | $71.26 | $356K | |
 Joe E. Kiani | Grant or award | Restricted Stock Units | 2,095 | $0.00 | - | |
| Roger E. Susi - Officer | Open-market sale | Common Stock | 3,454 | $71.00 | $245K | |
| Roger E. Susi - Officer | Open-market sale | Common Stock | 1,546 | $71.88 | $111K | |
| Monty K. Allen | Open-market sale | Common Stock | 1,102 | $69.10 | $76K | |
| John Glenn - Officer | Option exercise | Common Stock | 5,796 | - | - | |
| John Glenn - Officer | Tax withholding / forfeiture | Common Stock | 1,412 | $58.24 | $82K | |
| John Glenn - Officer | Option exercise | Restricted Stock Units | 5,796 | $0.00 | - | |
| John Glenn - Officer | Option exercise | Restricted Stock Units | 5,796 | $0.00 | - | |
| Jeff Chiprin - Officer | Grant or award | Restricted Stock Units | 2,990 | $0.00 | - | |
| Jeff Chiprin - Officer | Grant or award | Performance-based Restricted Stock Units | 2,989 | $0.00 | - | |
| Hilda Frederique Scharen-Guivel | Grant or award | Restricted Stock Units | 1,811 | $0.00 | - | |
| James B. Hawkins | Grant or award | Restricted Stock Units | 1,811 | $0.00 | - | |
| John Glenn - Officer | Grant or award | Restricted Stock Units | 5,436 | $0.00 | - | |
| John Glenn - Officer | Grant or award | Performance-based Restricted Stock Units | 5,435 | $0.00 | - | |
| Monty K. Allen | Grant or award | Restricted Stock Units | 1,811 | $0.00 | - | |
| Anthony Vuoto | Grant or award | Restricted Stock Units | 1,811 | $0.00 | - | |
| James B. Hawkins | Option exercise | Common Stock | 1,751 | - | - | |
| James B. Hawkins | Option exercise | Common Stock | 1,196 | - | - | |
| James B. Hawkins | Option exercise | Restricted Stock Units | 1,751 | $0.00 | - | |
| James B. Hawkins | Option exercise | Restricted Stock Units | 1,196 | $0.00 | - | |
| Hilda Frederique Scharen-Guivel | Option exercise | Common Stock | 1,196 | - | - | |
| Hilda Frederique Scharen-Guivel | Option exercise | Restricted Stock Units | 1,196 | $0.00 | - | |
| Monty K. Allen | Option exercise | Common Stock | 1,751 | - | - | |
| Monty K. Allen | Option exercise | Common Stock | 1,196 | - | - | |
| Monty K. Allen | Option exercise | Restricted Stock Units | 1,751 | $0.00 | - | |
| Monty K. Allen | Option exercise | Restricted Stock Units | 1,196 | $0.00 | - | |
| Anthony Vuoto | Option exercise | Common Stock | 1,751 | - | - | |
| Anthony Vuoto | Option exercise | Common Stock | 1,196 | - | - | |
| Anthony Vuoto | Option exercise | Restricted Stock Units | 1,751 | $0.00 | - | |
| Anthony Vuoto | Option exercise | Restricted Stock Units | 1,196 | $0.00 | - | |
| John Glenn - Officer | Open-market sale | Common Stock | 2,500 | $54.18 | $135K | |
| Anthony Vuoto | Open-market sale | Common Stock | 2,690 | $55.99 | $151K | |
| Hilda Frederique Scharen-Guivel | Option exercise | Common Stock | 1,767 | - | - | |
| Hilda Frederique Scharen-Guivel | Option exercise | Restricted Stock Units | 1,767 | $0.00 | - | |
Item 2.02, 9.01
Item 2.02, 9.01
Item 8.01
Item 5.07
Recent IRMD Form 144 notices of proposed sale
2An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Monty K. Allen | Director | 1,419 | $123K | View on EDGAR | |
| - | - | - | - |
IRMD insider trading FAQ
What is the latest insider trade for IRMD?
IRADIMED CORP (IRMD) had 2 insider filings in the last 90 days, with the most recent on 25 September 2026. The full record for IRMD runs to 55 Form 4 filings, the earliest from 15 October 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying IRMD stock?
No insider purchases of IRMD were filed in the last 90 days.
How many insiders are selling IRMD stock?
2 insider sales of IRMD were filed in the last 90 days, totaling $123K.
Where can I see IRMD SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects IRMD Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Joe E. Kiani view on EDGAR
- - Monty K. Allen view on EDGAR
- - John Glenn view on EDGAR
- - Hilda Frederique Scharen-Guivel view on EDGAR
- - Roger E. Susi view on EDGAR
- - Roger E. Susi view on EDGAR
- - Roger E. Susi view on EDGAR
- - Roger E. Susi view on EDGAR
- - Roger E. Susi view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where IRMD's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow IRMD with a 7-day demo
- IRMD on your watchlist
- Every IRMD Form 4 filing on record
- Up to 3 months of IRMD price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
